Figure 3
Figure 3. DLBCL patients with TP53 mutations in the LSH, L2, and L3 motifs of the DNA binding domain have significantly inferior OS and PFS compared with DLBCL patients with WT-TP53.

DLBCL patients with TP53 mutations in the LSH, L2, and L3 motifs of the DNA binding domain have significantly inferior OS and PFS compared with DLBCL patients with WT-TP53.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal